首页> 外国专利> Heterocyclic compounds useful for the control of Advanced Glycation End Products (AGEs)

Heterocyclic compounds useful for the control of Advanced Glycation End Products (AGEs)

机译:可用于控制高级糖基化终产物(AGEs)的杂环化合物

摘要

The preparation process of these compounds, the pharmaceutical ingredients containing these compounds, and their use in the treatment of diseases caused by the formation and accumulation of the elderly (Advanced glycerine products). Current compounds are effective tools for the treatment of complications related to aging and diabetes caused by the formation and accumulation of the elderly, such as neurological disorders, nephropathy, microvascular diseases, retinopathy, hypertension, heart failure, allergies,Alzheimer's disease and dermatological disorders. Claim 1: N '- (methylsulfonyl) -1- [2-oxo-2- (thiophene-2-yl) ethyl] -1,4-dihydropyridine-3-carbohydrazide and pharmaceutically acceptable salt thereof. Claim 2: A compound of the formula (1) and pharmaceutically acceptable salt thereof; where, the dotted line on the ring containing nitrogen represents: (a) two double junctions between either (i) in C2-3 and C5-6, or (ii) in C2-3 and C4-5, or ( iii) in C3-4 and C5-6, or (b) a double between either (i) in C2-3 or (ii) in C3-4 or (iii) in C4-5 or (iv) or in C5 -6, or (c) absence of double bonding ie a saturated ring system;R1 es-cor3 or 5 member aperiodic rings: (2);G1 and G2 are independent n, NH, nr12, s or form a heterocyclic ring system, which may be partially or completely saturated; G3 is - (C1-12) tar-p or - (C1-12) tar, where p is sulfur, oxygen or nitrogen, and N is 0 or 1; Z is 1) - ch2-c (o) - RX or II; Rx is R7, - n (R7) (R10),-N 3DC (R7) (R10)-N (R7) N (R7) (R10)-N (R7) N 3DC (R7) (R10)-CH (R7) C (o) R8 or a compound containing any of the following preparations: (3);Ry is selected from the group consisting of hydrogen, linear or branched (C1-12) alkyl, (C2-12) alkenyl, (C3-7) cycloalkyl, (C5-7) cycloalkenyl, bicycloalkyl, CH2 (CO) R13, CH2 (CO) NHR14, CH2 (CO) NR14R15 and CH2 (CO) OR13; R2 every time it appears is Halogen, OR7, NO2, alkyl, aryl, heterocyclyl, formyl, oxo, -NR7R10, -N = C (R7) (R10),Sr7-so2nh2-so2-asphalt-so2-arilo, n = C (R14) (R15)-Nr14r15, - or14, perhalogiel, - O (CO) R14, - NH (CO) R14, (c2-12) alquenilo, (c3-7) cycloquilo, (C5-7) cycloquilo, bicycloquilo, bicycloquilo, bicycloquinilo, hecycloquilo, O aralquilo; MES 0, 1, 2 or 3; R3 es-r4-r5, - n (R7) n (R9), or one of the following compounds:R4 is - n (R7) r6o -,-N (R7) R6N (R7) -OR6O or -OR6N (R7) -,R6 is aspha R5 is hydrogen, asphalt, arilo, isopropene, - cor7, so2r7, - C (s) nhr7, - C (= NH) nhr7, - cor10, - C (o) nhr7 or (5);wherein R7 is H, alkyl, aryl or heterocyclyl; R8 is R7, OR7 or NR7R10; R9 is selected from the group consisting of hydrogen, alkyl, aryl, heterocyclyl, C (O) R10, -SO2R10, -C (S) NHR10, -C (N = H) NH (R10) and -C (O) NHR10 ; R10 is selected from the group consisting of H, alkyl, alkoxy, aryl and heterocyclyl; R11 is selected from the group consisting of hydrogen, linear or branched (C1-12) alkyl, (C2-12) alkenyl, (C3-7) cycloalkyl, (C5-7) cycloalkenyl, bicycloalkyl, bicycloalkenyl, heterocycloalkyl, aryl, aralkyl , heterocyclyl and Compound (6),wherein in R11 one or more heteroatoms when present are independently O, N, or S and is optionally substituted, wherein the substituents are selected from a first group consisting of halogen, hydroxy, nitro, cyano, amino, oxo and oxime or of a second group consisting of, linear or branched, (C1-8) alkyl, (C3-7) cycloalkyl, alkylcycloalkyl, perhaloalkyl, perhalocycloalkyl, aryl, aralkyl, alkylaryl, aralkoxyalkyl, perhaloaryl, alkylheterocycloalkyl, heterocyclylalkyl, cycloalkyl, heterocyclyl, alkylcycloalkyl, heterocyclyl, alkylcycloalkyl, heterocyclyl, alkyl, cycloalkyl , perhaloheteroaryl, alkoxyalkyl, thioalkyl and thioaryl,In the case that the substance substituting for the second kind of substance is replaced by halogenated, hydrogen Xi, nitro, cyanogen, aminobenzene, oxo, hyperhalogenated tar (C1-6) and oxygen substitute, the substitute is - Co -- (CO) or -,- (CO) NH-- en...- No. fourteenth- that is...- yes.- (so)..- (SO2)- (SO2) NH-o -NH (CO) -R12 and R13 are selected independently from the following categories: a group of asphalt, asphalt, tar, perhalogiel, perhalocycloquilo, arilo, aralquilo, lease, aralcoxquilo, perhalarilo, asphalt, isocyclohexane, isocyclohexane, isocyclohexane, isocyclohexane, isocyclohexane and isocyclohexane, which are composed of one-way or separated daughter (c1-8) asphalt (c3-7), In these substances, the members of these substances can choose to use R16 instead; R14 and R15 can be independent of any group composed of the following substances: a linear or separated daughter (C1-12) asphalt, dioxane, alcoxicoquilo, alcocicycle, alcoid, alcoxiarilo, Over halogen(C2-12) alquenilo (C3-7) cicloalquilo perhalocicloalquilo haloheterocicloalquilo cianoheterocicloalquilo perhaloheterocicloalquilo (C5-7) cicloalquenilo bicicloalquilo bicicloalquenilo heterocicloalquilo arilo aralquilo heterociclilo perhaloarilo y perhaloheterociclil en donde los substituyentes de dicho grupo est n opcionalmente substituidos por R16 R16 es Halogeno hidroxi nitro ciano That is, if (I) R1 is - C (o) R3, then Z is - ch2-c (o) - RX; and (II) Z is - ch2-c (o) - Rx is O, then R7 is not hydrogen.
机译:这些化合物的制备方法,含有这些化合物的药物成分,以及它们在治疗老年人形成和蓄积所引起的疾病中的用途(高级甘油产品)。当前的化合物是用于治疗由老年人的形成和积累引起的与衰老和糖尿病有关的并发症的有效工具,例如神经系统疾病,肾病,微血管疾病,视网膜病,高血压,心力衰竭,过敏,阿尔茨海默氏病和皮肤病。权利要求1:N′-(甲基磺酰基)-1- [2-氧代-2-(噻吩-2-基)乙基] -1,4-二氢吡啶-3-碳酰肼及其药学上可接受的盐。权利要求2:式(1)化合物及其药学上可接受的盐。其中,含氮环上的虚线表示:(a)(i)在C2-3和C5-6中,或(ii)在C2-3和C4-5中,或(iii)中的两个双键C3-4和C5-6,或(b)(i)C2-3或(ii)C3-4或(iii)C4-5或(iv)或C5 -6的两倍。 (c)不存在双键即饱和环系统; R1 es-cor3或5元非周期性环:(2); G1和G2是独立的n,NH,nr12,s或形成杂环环系统,该环系统可能部分或完全饱和; G3为-(C1-12)焦油-p或-(C1-12)焦油,其中p为硫,氧或氮,N为0或1; Z是1)-ch2-c(o)-RX或II; Rx是R7,-n(R7)(R10),-N 3DC(R7)(R10)-N(R7)N(R7)(R10)-N(R7)N 3DC(R7)(R10)-CH( R7)C(o)R8或含有以下任何一种制备物的化合物:(3); Ry选自氢,直链或支链的(C1-12)烷基,(C2-12)烯基,(C3 -7)环烷基,(C5-7)环烯基,双环烷基,CH2(CO)R13,CH2(CO)NHR14,CH2(CO)NR14R15和CH2(CO)OR13;每次出现的R2是卤素,OR7,NO2,烷基,芳基,杂环基,甲酰基,氧代,-NR7R10,-N = C(R7)(R10),Sr7-so2nh2-so2-沥青-so2-芳基,n = C(R14)(R15)-Nr14r15,-or14,perhalogiel,-O(CO)R14,-NH(CO)R14,(c2-12)alquenilo,(c3-7)环基,(C5-7)环基, bicycloquilo,bicycloquilo,bicycloquinilo,hecycloquilo,O aralquilo; MES 0、1、2或3; R3 es-r4-r5,-n(R7)n(R9)或以下化合物之一:R4为-n(R7)r6o-,-N(R7)R6N(R7)-OR6O或-OR6N(R7 )-,R6为沥青; R5是氢,沥青,芳基,异丙基,-cor7,so2r7,-C(s)nhr7,-C(= NH)nhr7,-cor10,-C(o)nhr7或(5);其中R7是H,烷基,芳基或杂环基; R8是R7,OR7或NR7R10; R9选自氢,烷基,芳基,杂环基,C(O)R10,-SO2R10,-C(S)NHR10,-C(N = H)NH(R10)和-C(O)NHR10 ; R10选自H,烷基,烷氧基,芳基和杂环基; R11选自氢,直链或支链的(C1-12)烷基,(C2-12)烯基,(C3-7)环烷基,(C5-7)环烯基,双环烷基,双环烯基,杂环烷基,芳基,芳烷基,杂环基和化合物(6),其中在R11中,一个或多个杂原子(当存在时)独立地为O,N或S,并且任选地被取代,其中取代基选自卤素,羟基,硝基,氰基,氨基,氧代和肟或第二组由直链或支链的(C1-8)烷基,(C3-7)环烷基,烷基环烷基,全卤代烷基,全卤代环烷基,芳基,芳烷基,烷基芳基,芳烷氧基烷基,全卤代芳基,烷基杂环烷基,杂环基烷基,环烷基,杂环基,烷基环烷基,杂环基,烷基环烷基,杂环基,烷基,环烷基,全卤代杂芳基,烷氧基烷基,硫代烷基和硫代芳基,在取代第二种物质的物质被卤代氢,Xi,硝基,c取代的情况下氰,氨基苯,氧代,高卤焦油(C1-6)和氧的替代物,替代物是-Co-(CO)或-,-(CO)NH- en ...-第14位-.. .-是-(so)..-(SO2)-(SO2)NH-o -NH(CO)-R12和R13选自以下类别:一组沥青,沥青,焦油,Perhalogiel,全卤代喹啉,arilo,alalquilo,地契,aralcoxquilo,perhalarilo,沥青,异环己烷,异环己烷,异环己烷,异环己烷,异环己烷和异环己烷,它们由单向或分离的子代(c1-8)沥青(c3-7)组成,这些物质的成员可以选择使用R16代替; R14和R15可以独立于以下物质组成的任何基团:直链或分离的子代(C1-12)沥青,二恶烷,烷氧基喹啉,环丙沙星,allcoid,alcoxiarilo在卤素(C2-12)烯基(C3-7)上的环烷基全卤代环烷基卤代杂环烷基氰基杂环烷基烷基全卤代杂环烷基(C5-7)上的环烯基双环烷基双环烯基取代基杂环烷基芳基芳烷基全卤代烷基是任选的R16卤代杂环基即,如果(I)R 1为-C(o)R 3,则Z为-ch 2 -c(o)-RX; (II)Z是-ch2-c(o)-Rx是O,则R7不是氢。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号